CONTOUR Products®
MICROLET®NEXT Lancing Device
The new MICROLET®NEXT from Ascensia Diabetes Care. Minimize pain so you can test with confidence.
Overview
Features
- Locking end cap helps prevent accidental lancing
- 5 clearly visible depth settings
- Smooth-gliding mechanism to minimize noise
Product Features
SIMPLY IMPROVED
The easy-to-use MICROLET®NEXT lancing device is designed to help minimize pain so you can test with confidence.
New and Improved Features to Love:
- Locking endcap helps prevent accidental lancing
- 5 clearly visible depth settings
- Smooth-gliding mechanism to minimize noise
- Easy-to-use lancet ejector
- Uses silicone-coated MICROLET®lancets for smooth gliding into the skin
- Available in Seven (7) vibrant colours to allow colour coded testing
- Coloured lancets give you visual feedback to remind you to change your lancets more often
Get the free CONTOUR®DIABETES App here:
*95% of the measured glucose values needed to fall within either ±0.83 mmol/L (±15 mg/dL) of the average measured values of the reference measurement procedure at glucose concentrations <5.55 mmol/L (<100 mg/dL) or within ±15% at glucose concentrations ≥5.55 mmol/L (≥100 mg/dL). 99% of individual glucose measured values need to fall within zones A and B of the Consensus Error Grid (CEG) for type 1 diabetes.3
**On a compatible Android or iOS device. For a list of compatilbe operating systems, please visit compatibility.contourone.com
**On a compatible Android or iOS device. For a list of compatilbe operating systems, please visit compatibility.contourone.com
- CONTOUR®PLUS ONE BGMS User Guide Rev 01/16.
- Bailey TS. J Diabetes Sci Technol 2017 Jul;11(4):736-743.
- International Organization for Standardization. In vitro diagnostic test systems – requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus (ISO 15197). International Organization for Standardization, Geneva, Switzerland, 2013.
- Richardson JM et al. Clinical Relevance of Reapplication of Blood Samples During Blood Glucose Testing. Poster presented at the 20th Annual Diabetes Technology Meeting (DTM); November 12-14, 2020.